


Anoat Therapeutics raises €2M in seed funding to develop novel therapies for Cystic Fibrosis patients with high unmet medical need

DiogenX raises €27.5M Series A financing to advance its first-in-class regenerative treatment for type 1 diabetes towards clinical development
